DJ Vertex Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors Despite Daily Gains
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Vertex Pharmaceuticals Inc. $(VRTX)$ rose 1.88% to $470.37 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.76% to 5,994.57 and Dow Jones Industrial Average falling 0.28% to 44,421.91.
This was the stock's second consecutive day of gains.
Vertex Pharmaceuticals Inc. closed 9.52% below its 52-week high of $519.88, which the company achieved on November 8th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as AbbVie Inc. $(ABBV)$ rose 3.39% to $190.14, Krystal Biotech Inc. (KRYS) fell 0.44% to $159.03, and Arcturus Therapeutics Holdings Inc. $(ARCT)$ fell 6.89% to $15.80.
Trading volume (2.2 M) eclipsed its 50-day average volume of 1.7 M.
Data source: Dow Jones Market Data, FactSet. Data compiled February 3, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
February 03, 2025 16:38 ET (21:38 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。